Computer-aided prediction of QT-prolongationFootnote1

¹Presented at CMTPI 2007: Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (Moscow, Russia, September 1–5, 2007).

References

• Sanguinetti , M and Tristani-Firouzi , M . 2006 . hERG potassium channels and cardiac arrhythmia . Nature , 440 : 463 – 469 .
   PubMed Web of Science ®Google Scholar
• Thomas , D , Karle , CA and Kiehn , J . 2006 . The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation and clinical applications . Curr. Pharm. Des. , 12 : 2271 – 2383 .
   PubMed Web of Science ®Google Scholar
• Aptula , A and Cronin , M . 2004 . Prediction of hERG K+ blocking potency: application of structural knowledge . SAR QSAR Environ. Res. , 15 : 399 – 411 .
   PubMed Web of Science ®Google Scholar
• Aronov , A . 2005 . Predictive in silico modeling for hERG channel blockers . Drug. Discov. Today. , 10 : 149 – 155 .
   PubMed Web of Science ®Google Scholar
• Jamielson , C . 2006 . Medicinal chemistry of hERG optimizations: highlights and hang-ups . J. Med. Chem. , 49 : 5029 – 5046 .
   Google Scholar
• Roshe , O . 2002 . A virtual screening method for prediction of the hERG potassium channel liability of compounds libraries . ChemBioChem. , 3 : 455 – 459 .
   Google Scholar
• Cavalli , A . 2002 . Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of hERG K(+) channel blockers . J. Med. Chem. , 45 : 3844 – 3853 .
   PubMed Web of Science ®Google Scholar
• Keseru , G . 2003 . Prediction of hERG potassium channel affinity by traditional and hologram QSAR methods . Bioorg. Med. Chem. Lett. , 13 : 2773 – 2775 .
   PubMed Web of Science ®Google Scholar
• Pearlstein , R . 2003 . Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior . J. Med. Chem. , 46 : 2017 – 2022 .
   PubMed Web of Science ®Google Scholar
• Aronov , A and Goldman , B . 2004 . A model for identifying hERG K+ channel blockers . Bioorg. Med. Chem. , 12 : 2307 – 2315 .
   PubMed Web of Science ®Google Scholar
• Bains , W , Basman , A and White , C . 2004 . HERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study . Progr. Biophys. Mol. Biol. , 86 : 3153 – 3159 .
   Google Scholar
• Fernandez , D . 2004 . Physicochemical features of the hERG channel drug binding site . J. Biol. Chem. , 279 : 10120 – 10127 .
   PubMed Web of Science ®Google Scholar
• Du , L . 2005 . Characterization of binding site of close-state KCNQ1 potassium channel by homology modelling, molecular docking and pharmacophore identification . Biochem. Biophys. Res. Communs. , 332 : 677 – 687 .
   PubMed Web of Science ®Google Scholar
• Osterberg , F and Aqvist , J . 2005 . Exploring blocker binding to a homology model of the open hERG K+ channel using docking and molecular dynamics methods . FEBS Lett. , 579 : 2939 – 2944 .
   PubMed Web of Science ®Google Scholar
• Ekins , S . 2006 . Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques . J. Med. Chem. , 49 : 5059 – 5071 .
   PubMed Web of Science ®Google Scholar
• Aronov , A . 2006 . Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers . J. Med. Chem. , 49 : 6917 – 6921 .
   PubMed Web of Science ®Google Scholar
• Sierstad , M and Agrafiotis , D . 2006 . A QSAR model of hERG binding using a large, diverse and internally consistent training set . Chem. Biol. Drug. Des. , 67 : 284 – 296 .
   Google Scholar
• Coi , A . 2006 . Prediction of hERG potassium channel affinity by CODESSA approach . Bioorg. Med. Chem. , 14 : 3153 – 3159 .
   PubMed Web of Science ®Google Scholar
• Gepp , M and Hutter , M . 2006 . Determination of hERG channel blockers using a decision tree . Bioorg. Med. Chem. , 14 : 5325 – 5332 .
   PubMed Web of Science ®Google Scholar
• Lu , L . 2007 . A novel structure-based virtual screening model for the hERG channel blockers . Biochem. Biophys. Res. Communs. , 355 : 889 – 894 .
   Google Scholar
• Diller , D and Hobbs , D . 2007 . Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation . J. Comput. Aid. Mol. Des. , 21 : 379 – 393 .
   PubMed Web of Science ®Google Scholar
• Norinder , U . 2004 . In silico modelling of ADMET–A minireview of work from 2000 to 2004 . SAR QSAR Environ. Res. , 16 : 1 – 11 .
   Google Scholar
• Helma , C . 2005 . In silico predictive toxicology: the state-of-the-art and strategies to predict human health effects . Curr. Opin. Drug Discov. Devel. , 8 : 27 – 31 .
   Google Scholar
• O’Brien , SE and De Groot , MJ . 2005 . Greater than the sum of its parts: combining models for useful ADMET prediction . J. Med. Chem. , 48 : 1287 – 1291 .
   PubMed Web of Science ®Google Scholar
• Sangunietti , M and Mitcheson , J . 2005 . Predicting drug-hERG channel interactions that cause acquired long QT syndrome . Trends Pharmacol. Sci. , 26 : 119 – 124 .
   Google Scholar
• Sadym , A . 2003 . Prediction of biological activity spectra via the Internet . SAR QSAR Environ. Res. , 14 : 339 – 347 .
   PubMed Web of Science ®Google Scholar
• Poroikov , V . 2007 . PASS: Identification of probable targets and mechanisms of toxicity . SAR QSAR Environ. Res. , 18 : 101 – 110 .
   PubMed Web of Science ®Google Scholar
• Poroikov , V and Filimonov , D . 2005 . PASS: Prediction of Biological Activity Spectra for Substances, in Predictive Toxicology , Edited by: Helma , C . 459 – 478 . Boca Raton, , USA : Taylor & Francis .
   Google Scholar
• http://www.ibmc.msk.ru/PASS
   Google Scholar
• Poroikov , V . 2000 . Robustness of biological activity spectra predicting by computer program PASS for non-congeneric sets of chemical compounds . J. Chem. Inform. Comput. Sci. , 40 : 1349 – 1355 .
   PubMedGoogle Scholar
• Anson , B . 2005 . Blockade of HERG channels by HIV protease inhibitors . The Lancet. , 365 : 682 – 686 .
   PubMed Web of Science ®Google Scholar
• Fossa , A . 2004 . Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig . Eur. J. Pharmacol. , 486 : 209 – 221 .
   Google Scholar
• Guth , B . 2004 . Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization . J. Pharmacol Toxicol. Meth. , 49 : 159 – 69 .
   PubMedGoogle Scholar
• Hara , Y and Kizaki , K . 2002 . Antimalarial drugs inhibit the acetylcholine-receptor-operated potassium current in atrial myocytes . Heart Lung Circ. , 11 : 112 – 116 .
   Google Scholar
• Kongsamut , S . 2002 . A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs . Eur. J. Pharmacol. , 450 : 37 – 41 .
   PubMed Web of Science ®Google Scholar
• Milberg , P . 2005 . Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3 . Cardiovasc. Res. , 65 : 397 – 404 .
   Google Scholar
• Paakkari , I . 2002 . Cardiotoxicity of new antihistamines and cisapride . Toxicol. Lett. , 127 : 279 – 284 .
   PubMed Web of Science ®Google Scholar
• Remich , S , Kilborn , M and Woosley , R . 2001 . The role of internet-based registries in tandem with genetic screening for the study of drug-induced arrythmias . Curr. Ther. Res. , 62 : 787 – 795 .
   Google Scholar
• Vlaminckx , E . 2006 . In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation . Eur. J. Pharmacol. , 553 : 229 – 239 .
   Google Scholar
• Thomas , D . 2004 . Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin . Naunyn Schmiedebergs Arch Pharmacol. , 369 : 462 – 472 .
   PubMedGoogle Scholar
• Garg , D , Gandhi , T and Mohan , C . 2007 . Exploring QTSR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques . J. Mol. Graph. Model , [Epub ahead of print]
   Google Scholar
• Paul , A , Witchel , H and Hancox , J . 2001 . Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide . Biochem. Biophys. Res. Commun. , 280 : 1243 – 1250 .
   PubMed Web of Science ®Google Scholar
• Rajamani , S . 2006 . Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine . Br. J. Pharmacol. , 149 : 481 – 489 .
   PubMed Web of Science ®Google Scholar
• Lacerda , A . 2007 . Alfuzosin delays cardiac repolarization by a novel mechanism, J. Pharmacol. Exp. Ther. , [Epub ahead of print]
   Google Scholar
• http://www.mdl.com
   Google Scholar
• Poroikov , V , Lagunin , A and Filimonov , D . 2005 . “ Pharmaexpert: diseases, targets and ligands–three in one ” . In QSAR and Molecular Modelling in Rational Design of Bioactive Molecules , Edited by: Aki Sener , E and Yalcin , I . Ankara, , Turkey : CADD & D Society .
   Google Scholar
• http://www.brenda-enzymes.info R. Maas, Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA), Vasc. Med. 10 (2005), 49–57
   Google Scholar
• Berube , J , Chahine , M and Daleau , P . 1999 . Modulation of HERG potassium channel properties by external pH . Pflugers Arch. , 438 : 419 – 422 .
   Google Scholar
• Katayama , Y . 1995 . Nitric oxide: mysterious messenger . Dojindo Newsletter. , 1 : 1 – 26 .
   Google Scholar
• Sauviat , M and Pages , N . 2002 . Cardiotoxicity of lindane, a gamma isomer of hexachlorocyclohexane . J. Soc. Biol. , 196 : 339
   Google Scholar
• Wei , Z . 2002 . Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A . Chinese Med. Journ. , 115 : 668 – 676 .
   Google Scholar
• Corbett , E and Michalak , M . 2000 . Calcium, a signaling molecule in the endoplasmic reticulum? . Trends. Biochem. Sci. , 25 : 307 – 311 .
   PubMed Web of Science ®Google Scholar
• Rodriguez , I . 2001 . Drug-induced QT prolongation in women during the menstrual cycle . JAMA. , 285 : 1322 – 1326 .
   PubMed Web of Science ®Google Scholar